Not Medicare Enrolled

Dr. Ronald Henry, MD

Urology Physician · Shenandoah, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
135 VISION PARK BLVD, Shenandoah, TX 77384
2814043000
In practice since 2006 (20 years)
NPI: 1306806088 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Henry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Henry? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Henry

Dr. Ronald Henry is an urology physician in Shenandoah, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Henry performed 3,411 Medicare services across 1,642 unique beneficiaries.

Between the years covered by Open Payments, Dr. Henry received a total of $6,485 from 48 pharmaceutical and/or device companies across 262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Henry is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 34% volume in TX $6,485 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,411
Medicare services
Top 34% in TX for urology physician
1,642
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~171 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infectious disease DNA/RNA test 845 $34 $71
Urinalysis with microscopic exam 531 $3 $18
Yeast/candida DNA test 325 $34 $71
Office visit, established patient (20-29 min) 289 $58 $177
Office visit, established patient (30-39 min) 261 $77 $250
Bladder ultrasound after voiding 236 $7 $20
Blood draw (venipuncture) 214 $8 $12
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique 165 $69 $140
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique 65 $34 $72
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique 65 $34 $72
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique 65 $34 $71
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique 65 $34 $71
Leuprolide acetate (for depot suspension), 7.5 mg 60 $135 $695
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique 55 $34 $71
Ceftriaxone antibiotic injection 52 $0 $15
Diagnostic exam of bladder and urethra using an endoscope 43 $167 $483
Drug injection, under skin or into muscle 32 $10 $28
New patient office visit (45-59 min) 17 $79 $326
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle 15 $26 $65
Ultrasound scan of pelvic region through rectum 11 $104 $405
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,485
Total received (2018-2024)
Avg $926/year across 7 years
Top 31% in TX for urology physician
48
Companies
262
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,172 (95.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$313 (4.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$41
2023
$927
2022
$1,380
2021
$1,253
2020
$316
2019
$1,308
2018
$1,261

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$917
Janssen Biotech, Inc.
$782
PFIZER INC.
$680
Endo Pharmaceuticals Inc.
$378
Antares Pharma, Inc.
$323
Avadel Specialty Pharmaceuticals, LLC
$308
ABBVIE INC.
$291
Allergan Inc.
$240
Teleflex LLC
$179
Myriad Genetic Laboratories, Inc.
$165
Myovant Sciences Inc.
$152
COLOPLAST CORP
$149
Sumitomo Pharma America, Inc.
$143
AbbVie Inc.
$132
Novartis Pharmaceuticals Corporation
$124
AbbVie, Inc.
$111
UROGEN PHARMA, INC.
$110
UROVANT SCIENCES INC
$98
Axonics, Inc.
$98
Janssen Products, LP
$85
Olympus America Inc.
$74
Alnylam Pharmaceuticals Inc.
$74
MEDIVATION FIELD SOLUTIONS LLC
$71
Axonics Modulation Technologies, Inc.
$71
Allergan, Inc.
$66
C. R. Bard, Inc. & Subsidiaries
$63
C. R. BARD, INC. & SUBSIDIARIES
$59
Bayer HealthCare Pharmaceuticals Inc.
$51
Rochester Medical Corporation
$47
TherapeuticsMD, Inc.
$44
Supernus Pharmaceuticals, Inc.
$40
Dendreon Pharmaceuticals LLC
$36
PROCEPT BioRobotics Corporation
$27
Bayer Healthcare Pharmaceuticals Inc.
$26
Medtronic, Inc.
$25
Agiliti Surgical, Inc.
$24
Telix Pharmaceuticals
$24
Lantheus Medical Imaging, Inc.
$23
Tolmar, Inc.
$23
ConvaTec Inc.
$22
BOSTON SCIENTIFIC CORPORATION
$22
Retrophin, Inc.
$21
Boston Scientific Corporation
$19
Merck Sharp & Dohme LLC
$18
Hollister Incorporated
$17
Clarus Therapeutics Inc.
$13
Acerus Pharmaceuticals Corporation
$12
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 36.7% of total payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM ROBOTIC SYSTEM · AVEED · AVYCAZ · Altis · Androgel · Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · Bard Urinary Drainage Bag · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL THERAPIES · GENERAL BPH · GENTLECATH · GILENYA · ILLUCCIX · IMVEXXY · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Olympus Cysto-Resection · Olympus Laser Devices · Onli · Otrexup · PROLARIS · PROVENGE · Quadramet · TLANDO · TOVIAZ · UroLift System · UroPass · XIAFLEX · XTANDI · XYOSTED · Xofigo · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $190 per 100 Medicare services performed
Looking for an urology physician in Shenandoah?
Compare urology physicians in the Shenandoah area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
41
Per 100K population
6.3
County median income
$97,266
Nearest hospital
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Henry is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Henry experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Henry performed 845 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Henry receive payments from pharmaceutical companies?
Yes. Dr. Henry received a total of $6,485 from 48 companies across 262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Henry's costs compare to other urology physicians in Shenandoah?
Dr. Henry's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Henry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →